SiRNA conjugate, preparation method therefor and use thereof
AssigneeSuzhou Ribo Life Science Co., Ltd.
InventorsHongyan Zhang, Shan Gao, Daiwu Kang, Gengrong Chen
Life of this patent
Estimating the term…
Loading patent…
AssigneeSuzhou Ribo Life Science Co., Ltd.
InventorsHongyan Zhang, Shan Gao, Daiwu Kang, Gengrong Chen
Estimating the term…
An siRNA conjugate having a structure as represented by formula (1) for inhibiting hepatitis B vims gene expression, comprising siRNA and a conjugated group, wherein the sense strand of the siRNA comprises a nucleotide sequence 1, and the antisense strand comprises a nucleotide sequence 2; the nucleotide sequence 1 and the nucleotide sequence 2 are, at least in part, reversely complementary to form a double-stranded region; the nucleotide sequence 1 and SEQ ID NO: 1 are equal in length and differ by no more than three nucleotides; the nucleotide sequence 2 and SEQ ID NO: 2 are equal in length and differ by no more than three nucleotides. The siRNA conjugate can specifically target liver cells and effectively solve the problem of siRNA delivery in vivo, and shows excellent activity and low toxicity to inhibit HBV gene expression while maintaining high stability of siRNA.
A siRNA conjugate having the structure as shown by Formula (1):
Dependencies are inferred from the claim text.